Publication | Closed Access

PL-3 Results of the randomized international adjuvant lung cancer trial (IALT): Cisplatin-based chemotherapy (CT) vs no CT in 1867 patients (PTS) with resected non-small cell lung cancer (NSCLC)

Cisplatin-based ChemotherapyMedicinePl-3 ResultsMetronomic TherapyClinical TrialsBronchial NeoplasmCancer TreatmentOncologyRadiation OncologyLung CancerRadiologyHealth Sciences